Investigational Site Number :3920003

Okayama, Okayama-ken 701-1192

0 studies enrolling now · 2 studies all time

What they study most

Plasma Cell Myeloma

Studies at this site

• Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma — Running, not enrolling
• Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients — Completed